New Stock News | Sirio Pharma (300791.SZ) submitted an application to the Hong Kong Stock Exchange

According to the disclosure of the Hong Kong Stock Exchange on January 29, Sirio Pharma Technology Co., Ltd. (referred to as Sirio Pharma, 300791.SZ) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CITIC SEC as its exclusive sponsor. The company is a leading provider of nutritional and health food solutions. According to data from Zhishi Consultancy, based on revenue projections for 2024, the company holds the third largest market share in the global nutritional and health food solutions market, and ranks first in the Chinese market. In addition, according to Zhishi Consultancy data, based on revenue projections for 2024, the company ranks as the second largest provider of gummy and soft capsule nutritional and health food solutions globally. According to the prospectus, the company was founded in 1993. With a deep understanding of health demands, the company's strategic focus has gradually shifted from pharmaceuticals to the field of nutritional and health foods. Over the past 33 years of vigorous development, the company has established a comprehensive portfolio of solutions, covering a wide range of products in various dosage forms for all age groups, and has received support from a diverse customer base across multiple business models.